Interstitial lung disease with pulmonary fibrosis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Meeting the clinical diagnostic criteria for interstitial lung disease with interstitial fibrotic changes. 2.Acupoint thermal sensitivity within the two lateral lines of the dorsal foot and solar bladder meridian, in the area between the two horizontal lines of the lung and diaphragm points, or in the area between the first and second intercostal spaces of the anterior chest from the inside out to within 6 inches. 3.Age = 18 years, no restriction on gender. 4.patients can correctly express the sensation of moxibustion. 5.voluntarily sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1.patients being treated with medications that have a clear efficacy in interstitial fibrosis of the lung, such as Tanshinone IIA sodium sulfonate, lanosterone injection, corticosteroids or immunosuppressive drugs. 2.combination of serious primary or end-stage disease of the heart, brain, liver or kidney. 3.complicated respiratory failure requiring tracheal intubation and invasive ventilator-assisted breathing. 4.children, pregnant and lactating women. 5.allergy to the ingredients of the drug. 6.intolerance to mugwort. 7.mental illness, unable to cooperate with the study. 8.unwilling to provide personal information and are unable to sign the informed consent form.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| FVC% change from baseline; | — |
Secondary
| Measure | Time frame |
|---|---|
| Chinese Medicine Symptom Score;Respiratory distress score;St George's Breathing Questionnaire score;6 minutes walking distance;forced expiratory volume in one second;total lung capacity;carbon monoxide diffusion;partial pressure of oxygen;partial pressure of carbon dioxide;oxygen saturation; | — |
Countries
China
Contacts
The Affiliated Hospital of Jiangxi University of Chinese Medicine